Trough concentrations of vancomycin in patients undergoing extracorporeal membrane oxygenation

PLoS ONE

Volumn 10, Issue 11, 2015, Pages

  Park, So Jin ^a   Yang, Jeong Hoon ^b   Park, Hyo Jung ^a   In, Yong Won ^a   Lee, Young Mi ^a   Cho, Yang Hyun ^b   Chung, Chi Ryang ^b   Park, Chi Min ^b   Jeon, Kyeongman ^b   Suh, Gee Young ^b  

^a Samsung Medical Center   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ARTICLE; CATHETER INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG TROUGH LEVEL; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; MALE; PHARMACOKINETIC PARAMETERS; STEADY STATE; VENTILATOR ASSOCIATED PNEUMONIA; AGED; CRITICAL ILLNESS; METABOLIC CLEARANCE RATE; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; TISSUE DISTRIBUTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CRITICAL ILLNESS; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; HUMANS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; RETROSPECTIVE STUDIES; TISSUE DISTRIBUTION; VANCOMYCIN;

EID: 84953208629     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0141016     Document Type: Article

References (15)

1. Shekar K, Roberts JA, Welch S, Buscher H., Rudham S, Burrows F, et al ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. BMC Anesthesiol. 2012; 12: 29. doi: 10.1186/1471-2253-12-29 PMID: 23190792
2. Shekar K, Fraser JF, Smith M.T., Roberts JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J CritCare. 2012; 27: 741. e9-18.
3. Amaker RD, DiPiro JT, Bhatia J. Pharmacokinetics of vancomycin in critically ill infants undergoing extracorporeal membrane oxygenation. Antimicrob Agents Chemother. 1996; 40:1139-1142. PMID: 8723454
4. Rybak M, Lomaestro B, Rotschafer J.C., Moellering R Jr., Craig W, Billeter M, et al. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009; 66: 82-98. doi: 10.2146/ajhp080434 PMID: 19106348
5. Parekh T, Gowda A, Shah S., Nishi S. 978: Vancomycin dosing and initial trough levels in critically ill patients. CritCare Med. 2012; 40Suppl 1:1-328.
6. Kumar A, Roberts D, Wood K.E., Light B., Parrillo JE, SharmaS, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006; 34:1589-1596. PMID: 16625125
7. Winter ME. Basic clinical pharmacokinetics. 5th ed. Baltimore: Lippincott Williams & Wilkins; 2010. pp. 2-114, 459-487.
8. Barriere SL, Stryjewski ME, Corey G.R., Genter FC, Rubinstein E. Effect of vancomycin serum trough levels on outcomes in patients with nosocomial pneumonia due to Staphylococcus aureus: a retrospective, post hoc, subgroup analysis of the Phase 3 ATTAIN studies. BMC Infect Dis. 2014; 14:183. doi: 10.1186/1471-2334-14-183 PMID: 24708675
9. Mulla H, Pooboni S. Population pharmacokinetics of vancomycin in patients receiving extracorporeal membrane oxygenation. Br J Clin Pharmacol. 2005; 60: 265-275. PMID: 16120065
10. Covajes C, Scolletta S, Penaccini L., Ocampos-Martinez E, Abdelhadii A, Beumier M, et al. Continuous infusion of vancomycin in septic patients receiving continuous renal replacement therapy. Int J Antimicrob Agents. 2013; 41: 261-266. doi: 10.1016/j.ijantimicag.2012.10.018 PMID: 23312601
11. Ocampos-Martinez E., Penaccini L, Scolletta S., Abdelhadii A, Devigili A, Cianferoni S., et al. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents. 2012; 39: 332-337. doi: 10.1016/j.ijantimicag.2011.12.008 PMID: 22333933
12. Kim DI, Im MS, Choi J.H., Lee J., Choi EH, Lee HJ. Therapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients. Korean J Pediatr. 2010; 53:1000-1005. doi: 10.3345/kjp.2010.53.12.1000 PMID: 21253314
13. Chung J, Oh JM, Cho E.M., Jang HJ, Hong SB, Lim CM, et al Optimal dose of vancomycin for treating methicillin-resistant Staphylococcus aureus pneumonia in critically ill patients. Anaesth Intensive Care. 2011; 39:1030-1037. PMID: 22165354
14. Nunn MO, Corallo CE, Aubron C, Poole S., Dooley MJ, Cheng AC. Vancomycin dosing: assessment of time to therapeutic concentration and predictive accuracy of pharmacokinetic modeling software. Ann Pharmacother. 2011; 45: 757-763. doi: 10.1345/aph.1P634 PMID: 21652786
15. De Waele J.J., Danneels I, Depuydt P., Decruyenaere J, Bourgeois M, Hoste E. Factors associated with inadequate early vancomycin levels in critically ill patients treated with continuous infusion. Int J Antimicrob Agents. 2013; 41: 434-438. doi: 10.1016/j.ijantimicag.2012.12.015 PMID: 23410793